• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Raptor Pharmaceutical Corp

+ Add to Watchlist

RPTP:US

9.4000 USD 0.4100 4.18%

As of 20:10:00 ET on 11/26/2014.

Snapshot for Raptor Pharmaceutical Corp (RPTP)

Open: 9.7900 Day's Range: 9.3000 - 9.8700 Volume: 2,391,385
Previous Close: 9.8100 52wk Range: 7.1200 - 17.7200 1-Yr Rtn: -32.33%

Stock Chart for RPTP

No chart data available.
  • RPTP:US 9.4000
  • 1D
  • 1M
  • 1Y
9.8100
Interactive RPTP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for RPTP

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.7400
Est. EPS (USD) (12/2014) -0.7200
Est. PEG Ratio -
Market Cap (M USD) 597.50
Shares Outstanding (M) 63.56
30 Day Average Volume 613,920
Price/Book (mrq) 33.4509
Price/Sale (ttm) 9.3966
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/13/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for RPTP

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for RPTP

Raptor Pharmaceuticals Corporation provides medical research services. The Company develops, manufactures, and commercializes medicines and clinical treatment for neurodegenerative disorder and liver disease. Raptor Pharmaceuticals serves the medical field worldwide.

Christopher M StarrCEO/Co-FounderJulie Anne SmithPresident/CEO-Designate
David HappelChief Commercial OfficerThomas E Daley "Ted"Chief Business Officer
More Company Profile & Key Executives for RPTP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil